Management of Rising WBC in Patient on Zosyn for Sacral Wound Infection

Clinical Assessment Priority

The Infectious Diseases Society of America recommends examining the wound directly for purulent drainage, increasing erythema beyond 5 cm from wound margins, induration, necrosis, or signs suggesting deeper tissue involvement 1, 2
The Infectious Diseases Society of America suggests assessing for systemic toxicity: temperature >38.5°C, heart rate >110 beats/minute, hypotension, or altered mental status 1
The Infectious Diseases Society of America recommends evaluating wound characteristics: presence of foul-smelling discharge, crepitus, or rapid progression that might suggest necrotizing infection 1

Elevated WBC >14,000 cells/mm³ warrants careful assessment for bacterial infection, but does not automatically indicate treatment failure 3
The trend matters more than a single value—a gradually rising WBC over several days despite appropriate antibiotics is more concerning than day-to-day fluctuation 4
Left shift is more predictive: if available, check whether band neutrophils are ≥16% or absolute band count ≥1,500 cells/mm³, which has a likelihood ratio of 14.5 for bacterial infection 3

The Infectious Diseases Society of America recommends continuing current Zosyn therapy if the patient has minimal systemic signs (temperature <38.5°C, WBC <15,000, HR <100) 1
Ensure adequate wound care: dressing changes, debridement of any necrotic tissue 1, 2
Recheck WBC in 24-48 hours to assess trend 4
Obtain wound cultures if not already done to guide potential antibiotic adjustment 1, 2

Do not change antibiotics based solely on a modest WBC increase without clinical correlation—this can lead to unnecessary antibiotic escalation and resistance 1, 2
Do not overlook the need for source control: antibiotics alone are insufficient if there is undrained pus, necrotic tissue, or osteomyelitis requiring debridement 1, 2
Do not assume treatment failure within the first 48-72 hours unless there is clear clinical deterioration—most infections require this time to show improvement 1

Consider modifying the antibiotic regimen if no clinical improvement after 48-72 hours of appropriate therapy with adequate source control 1
Clinical deterioration with worsening systemic signs despite therapy warrants a change in therapy 1, 2
Broaden coverage empirically if clinical deterioration occurs: consider adding vancomycin for MRSA coverage or switching to a carbapenem if multidrug-resistant organisms are suspected 5, 6